BLVR Requires Revision in 20% of Patients

Approximately 20% of patients who undergo bronchoscopic lung volume reduction (BLVR) lose the effects of the treatment within 2 years, according to data presented at the American Thoracic Society (ATS) 2025 International Conference in San Francisco. Although BLVR has become common, data on the need and reasons for revision are limited…